News Release
Third quarter 2021 net income from continuing operations was
Third Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations for Aluminum Extrusions of
$12.0 million was$4.5 million lower than the third quarter of 2020 -
EBITDA from ongoing operations for
PE Films of$4.8 million was$1.2 million lower than the third quarter of 2020 -
EBITDA from ongoing operations for
Flexible Packaging Films of$7.4 million was$2.2 million lower than the third quarter of 2020
THE IMPACT OF COVID-19 AND RELATED FINANCIAL CONSIDERATIONS
Essential Business and Employee Considerations
The Company’s priorities during the coronavirus ("COVID-19") pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. The Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to evolve as the
The Company has engaged in an education campaign that provides employees with the most accurate and up-to-date information related to COVID-19 vaccines and has offered different monetary and/or time-away-from-work incentives to encourage employees to get vaccinated. While the Company believes that these efforts have encouraged employees to be vaccinated, vaccination rates in its
All three of the Company's business segments are managing through supply chain disruptions and escalating costs, including raw material cost increases, shortages, transportation cost increases and delays. To offset growing cost pressures,
Financial Considerations
Approximately 62% of Bonnell Aluminum’s sales volume in 2020 was related to building and construction (“B&C”) markets (non-residential B&C of 55% and residential B&C of 7%). Non-residential B&C volume started to decline in the fourth quarter of 2020 after the fulfillment of contracts that existed at the start of the COVID-19 pandemic. Recently, market demand in this sector has been strong but was not reflected in
The Surface Protection component of
At Terphane, the Company believes that the pandemic-related surge in demand for flexible packaging films that began in early 2020 returned to lower pre-pandemic levels during the second quarter of 2021. Also, production and sales volumes for Terphane during the third quarter of 2021 were adversely impacted by an equipment failure on a manufacturing line that was unrelated to the pandemic and supply chain restrictions, which Terphane believes are impacting others in the industry as well. While the equipment failure is not expected to be fixed until early in 2022, Terphane has adjusted operations for the interim period to meet anticipated customer demand.
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions, which is also referred to as
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
|
Nine Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||||||
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
||||||||||||||
Sales volume (lbs) |
45,407 |
|
|
|
48,859 |
|
|
|
(7.1 |
)% |
|
138,793 |
|
|
|
139,985 |
|
|
|
(0.9 |
)% |
||||
Net sales |
$ |
137,086 |
|
|
|
$ |
115,621 |
|
|
|
18.6 |
% |
|
$ |
394,492 |
|
|
|
$ |
339,566 |
|
|
|
16.2 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
12,038 |
|
|
|
$ |
16,540 |
|
|
|
(27.2 |
)% |
|
$ |
45,062 |
|
|
|
$ |
41,496 |
|
|
|
8.6 |
% |
Depreciation & amortization |
(3,900 |
) |
|
|
(4,251 |
) |
|
|
8.3 |
% |
|
(12,062 |
) |
|
|
(12,632 |
) |
|
|
4.5 |
% |
||||
EBIT* |
$ |
8,138 |
|
|
|
$ |
12,289 |
|
|
|
(33.8 |
)% |
|
$ |
33,000 |
|
|
|
$ |
28,864 |
|
|
|
14.3 |
% |
Capital expenditures |
$ |
5,183 |
|
|
|
$ |
1,784 |
|
|
|
|
|
$ |
11,956 |
|
|
|
$ |
4,713 |
|
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Third Quarter 2021 Results vs. Third Quarter 2020 Results
Net sales (sales less freight) in the third quarter of 2021 increased versus the third quarter of 2020, primarily due to the pass-through of higher metal costs and an increase in average selling prices to cover higher operating costs, partially offset by lower volume. Sales volume in the third quarter of 2021 decreased by 7.1% versus the third quarter of 2020. Sales volume associated with the non-residential B&C market, which represented 55% of volume in 2020, declined 13.1% in the third quarter of 2021 versus the third quarter of 2020. Sales volume associated with specialty markets, which represented 31% of total volume in 2020, increased 11.4% in the third quarter of 2021 versus the third quarter of 2020, and sales volume associated with the automotive market, which represented 9% of total volume in 2020, decreased 34.9% in the third quarter of 2021 versus the third quarter of 2020. A portion of the decline in automotive sales was attributed to the supply chain issues in the automotive industry. See “The Impact of COVID-19 and Related Financial Considerations” section for more information on business conditions.
EBITDA from ongoing operations in the third quarter of 2021 decreased by
First Nine Months of 2021 Results vs. First Nine Months 2020 Results
Net sales in the first nine months of 2021 increased versus the first nine months of 2020, primarily due to the pass-through of higher metal costs and an increase in average selling prices to cover higher operating costs, partially offset by lower volume. Sales volume in the first nine months of 2021 decreased by 0.9% versus the first nine months of 2020.
EBITDA from ongoing operations in the first nine months of 2021 increased by
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
|
Nine Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||||||
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
||||||||||||||
Sales volume (lbs) |
9,283 |
|
|
|
9,556 |
|
|
|
(2.9 |
)% |
|
30,066 |
|
|
|
33,348 |
|
|
|
(9.8 |
)% |
||||
Net sales |
$ |
28,501 |
|
|
|
$ |
26,440 |
|
|
|
7.8 |
% |
|
$ |
87,885 |
|
|
|
$ |
103,444 |
|
|
|
(15.0 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
4,821 |
|
|
|
$ |
6,041 |
|
|
|
(20.2 |
)% |
|
$ |
21,035 |
|
|
|
$ |
33,928 |
|
|
|
(38.0 |
)% |
Depreciation & amortization |
(1,591 |
) |
|
|
(1,785 |
) |
|
|
10.9 |
% |
|
(4,681 |
) |
|
|
(4,868 |
) |
|
|
3.8 |
% |
||||
EBIT* |
$ |
3,230 |
|
|
|
$ |
4,256 |
|
|
|
(24.1 |
)% |
|
$ |
16,354 |
|
|
|
$ |
29,060 |
|
|
|
(43.7 |
)% |
Capital expenditures |
$ |
1,023 |
|
|
|
$ |
187 |
|
|
|
|
|
$ |
2,757 |
|
|
|
$ |
3,231 |
|
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Third Quarter 2021 Results vs. Third Quarter 2020 Results
Net sales increased by
EBITDA from ongoing operations in the third quarter of 2021 decreased by
-
A
$1.3 million decrease from Surface Protection related to lower sales associated with the customer product transitions ($1.6 million ), margin erosion associated with higher resin costs that occurred before the resin index pricing plan was fully implemented ($0.5 million ) and the pass-through lag associated with higher resin costs ($0.3 million ), partially offset by higher sales for products unrelated to the customer product transitions ($0.3 million ), lower fixed costs ($0.5 million ) and lower selling, general, and administrative expenses ($0.3 million ); -
A
$0.4 million decrease fromPottsville Packaging primarily related to the pass-through lag associated with higher resin costs; and -
A
$0.9 million favorable variance associated with the divestiture of Bright View Technologies at the end of 2020.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk of the Company's Form 10-Q for the period ended
Customer Product Transitions and Other Factors in Surface Protection
The Surface Protection component of
The Company previously reported the risk that a portion of its film products used in surface protection applications would be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates that these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for
The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately
First Nine Months of 2021 Results vs. First Nine Months 2020 Results
Net sales in the first nine months of 2021 decreased versus the first nine months 2020, primarily due to lower volume and unfavorable mix associated with the previously disclosed customer product transitions in Surface Protection, partially offset by higher pricing associated with the pass-through of increased resin costs.
EBITDA from ongoing operations in the first nine months of 2021 decreased by
-
A
$12.5 million decrease from Surface Protection primarily related to lower sales and unfavorable mix associated with the customer product transitions ($14.6 million ), margin erosion associated with higher resin costs that occurred before the resin index pricing plan was fully implemented ($1.4 million ) and the pass-through lag associated with higher resin costs ($1.0 million ), partially offset by higher sales of products unrelated to the customer product transitions ($0.9 million ) and production efficiencies and cost savings ($2.8 million ); -
A
$1.4 million decrease fromPottsville Packaging primarily related to the pass-through lag associated with higher resin costs; and -
A
$1.6 million favorable variance associated with the divestiture of Bright View Technologies at the end of 2020.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
|
Nine Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||||||
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
||||||||||||||
Sales volume (lbs) |
27,029 |
|
|
|
30,115 |
|
|
|
(10.2 |
)% |
|
78,666 |
|
|
|
85,059 |
|
|
|
(7.5 |
)% |
||||
Net sales |
$ |
36,666 |
|
|
|
$ |
35,856 |
|
|
|
2.3 |
% |
|
$ |
102,560 |
|
|
|
$ |
100,534 |
|
|
|
2.0 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
7,396 |
|
|
|
$ |
9,546 |
|
|
|
(22.5 |
)% |
|
$ |
25,296 |
|
|
|
$ |
22,594 |
|
|
|
12.0 |
% |
Depreciation & amortization |
(493 |
) |
|
|
(443 |
) |
|
|
(11.3 |
)% |
|
(1,466 |
) |
|
|
(1,306 |
) |
|
|
(12.3 |
)% |
||||
EBIT* |
$ |
6,903 |
|
|
|
$ |
9,103 |
|
|
|
(24.2 |
)% |
|
$ |
23,830 |
|
|
|
$ |
21,288 |
|
|
|
11.9 |
% |
Capital expenditures |
$ |
1,895 |
|
|
|
$ |
1,183 |
|
|
|
|
|
$ |
4,283 |
|
|
|
$ |
2,448 |
|
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Third Quarter 2021 Results vs. Third Quarter 2020 Results
Sales volume declined by 10.2% during the third quarter of 2021 versus the third quarter of 2020, primarily due to lower demand, reduced production capacity as a result of an equipment failure on a production line and supply chain restrictions, which Terphane believes are impacting others in the industry as well. While the equipment failure is not expected to be fixed until early in 2022, Terphane has adjusted operations for the interim period to meet anticipated customer demand. Net sales in the third quarter of 2021 increased 2.3% compared to the third quarter of 2020, primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.
EBITDA from ongoing operations in the third quarter of 2021 decreased by
-
Lower sales volume (
$1.8 million ), higher raw material costs ($4.8 million ) and higher selling and general administration expenses ($0.1 million ), partially offset by higher selling prices ($3.4 million ) from the pass-through of higher resin costs; -
Net favorable foreign currency translation of Real-denominated operating costs (
$1.1 million ); and -
Higher foreign currency transaction gains (
$0.2 million ) in the third quarter of 2021 versus the third quarter of 2020.
First Nine Months of 2021 Results vs. First Nine Months 2020 Results
Sales volume declined by 7.5% during the first nine months of 2021 versus the first nine months of 2020, primarily due to temporary resin supply issues, an equipment failure impacting production and lower demand. The Company believes that the pandemic-related surge in demand that began in early 2020 returned to lower pre-pandemic levels during the second quarter of 2021. Net sales in the first nine months of 2021 increased 2.0% compared to the first nine months of 2020, primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.
EBITDA from ongoing operations in the first nine months of 2021 increased by
-
Favorable product mix (
$1.7 million ), higher selling prices from the pass-through of higher resin costs ($0.8 million ), and lower selling and general administration expenses ($0.4 million ), offset by lower sales volume ($3.5 million ) and higher fixed ($0.8 million ) and variable ($0.4 million ) costs; -
Net favorable currency translation of Real-denominated operating costs (
$4.7 million ); -
Higher foreign currency transaction gains (
$0.3 million ) in the first nine months of 2021 versus 2020; and -
Lower value-added tax credits received in the first nine months of 2021 (
$0.5 million ) compared with the first nine months of 2020 ($1.2 million ).
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
Corporate Expenses, Interest, Taxes & Other
Corporate expenses, net, increased in the first nine months of 2021 versus the first nine months of 2020, primarily due to higher professional fees related to remediation activities of previously disclosed material weaknesses in the Company’s internal control over financial reporting (
Interest expense was
The effective tax rate used to compute income tax expense (benefit) for continuing operations in the first nine months of 2021 was 22.7%, compared to 26.2% in the first nine months of 2020. The effective tax rate from ongoing operations comparable to the earnings reconciliation table provided in Note (a) of the Notes to Financial Tables in this press release was 22.7% for the first nine months of 2021 versus 20.4% for the first nine months of 2020 (see also Note (f) of the Notes to Financial Tables). Refer to Note 12 of the Company's Form 10-Q for the period ended
Pension expense was
Tredegar owns approximately 18% of kaleo, Inc. (“kaléo”), which makes and sells an epinephrine delivery device under the name AUVI-Q®. The Company accounts for its investment in kaléo using a fair value method. The Company’s estimate of the fair value of its interest in kaléo at
Total debt was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the ultimate impact of the pandemic on employees, supply chains, customers and the
- loss or gain of sales to significant customers on which the Company's business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of the Company's customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our international operations; - political, economic, and regulatory factors concerning the Company's products;
- uncertain economic conditions in countries in which the Company does business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of the Company's underfunded defined benefit pension plan liability;
- an increase in the operating costs incurred by the Company's business units, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruptions to the Company's manufacturing facilities, including those resulting from labor shortages;
- the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
- an information technology system failure or breach;
- volatility and uncertainty of the valuation of the Company's investment in kaléo;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ; -
the impact of new tariffs, duties or other trade restrictions imposed as a result of rising trade tensions between the
U.S. and other countries; -
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging ; - failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material Company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
||||||||||||||||||||
Condensed Consolidated Statements of Income (Loss) |
||||||||||||||||||||
(In Thousands, Except Per-Share Data) |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
|
||||||||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||||||
Sales |
|
$ |
209,517 |
|
|
|
$ |
184,370 |
|
|
|
$ |
605,468 |
|
|
|
$ |
562,766 |
|
|
Other income (expense), net (c)(d)(h) |
|
391 |
|
|
|
(37,934 |
) |
|
|
9,272 |
|
|
|
(63,898 |
) |
|
||||
|
|
209,908 |
|
|
|
146,436 |
|
|
|
614,740 |
|
|
|
498,868 |
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of goods sold (c) |
|
170,756 |
|
|
|
136,008 |
|
|
|
470,733 |
|
|
|
415,212 |
|
|
||||
Freight |
|
7,264 |
|
|
|
6,453 |
|
|
|
20,531 |
|
|
|
19,222 |
|
|
||||
Selling, R&D and general expenses (c) |
|
18,380 |
|
|
|
22,076 |
|
|
|
60,192 |
|
|
|
67,717 |
|
|
||||
Amortization of intangibles |
|
724 |
|
|
|
753 |
|
|
|
2,170 |
|
|
|
2,264 |
|
|
||||
Pension and postretirement benefits |
|
3,540 |
|
|
|
3,567 |
|
|
|
10,622 |
|
|
|
10,701 |
|
|
||||
Interest expense |
|
842 |
|
|
|
494 |
|
|
|
2,555 |
|
|
|
1,598 |
|
|
||||
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
265 |
|
|
|
3 |
|
|
|
633 |
|
|
|
74 |
|
|
||||
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,696 |
|
|
||||
|
|
201,771 |
|
|
|
169,354 |
|
|
|
567,436 |
|
|
|
530,484 |
|
|
||||
Income (loss) from continuing operations before income taxes |
|
8,137 |
|
|
|
(22,918 |
) |
|
|
47,304 |
|
|
|
(31,616 |
) |
|
||||
Income tax expense (benefit) (c) |
|
1,908 |
|
|
|
(5,942 |
) |
|
|
10,728 |
|
|
|
(8,308 |
) |
|
||||
Net income (loss) from continuing operations |
|
6,229 |
|
|
|
(16,976 |
) |
|
|
36,576 |
|
|
|
(23,308 |
) |
|
||||
Income (loss) from discontinued operations, net of tax |
|
(26 |
) |
|
|
(48,237 |
) |
|
|
(104 |
) |
|
|
(53,031 |
) |
|
||||
Net income (loss) |
|
$ |
6,203 |
|
|
|
$ |
(65,213 |
) |
|
|
$ |
36,472 |
|
|
|
$ |
(76,339 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||||||
Continuing operations |
|
$ |
0.19 |
|
|
|
$ |
(0.51 |
) |
|
|
$ |
1.09 |
|
|
|
$ |
(0.70 |
) |
|
Discontinued operations |
|
— |
|
|
|
(1.44 |
) |
|
|
— |
|
|
|
(1.59 |
) |
|
||||
Basic earnings (loss) per share |
|
$ |
0.19 |
|
|
|
$ |
(1.95 |
) |
|
|
$ |
1.09 |
|
|
|
$ |
(2.29 |
) |
|
Diluted: |
|
|
|
|
|
|
|
|
||||||||||||
Continuing operations |
|
$ |
0.19 |
|
|
|
$ |
(0.51 |
) |
|
|
$ |
1.09 |
|
|
|
$ |
(0.70 |
) |
|
Discontinued operations |
|
— |
|
|
|
(1.44 |
) |
|
|
— |
|
|
|
(1.59 |
) |
|
||||
Diluted earnings (loss) per share |
|
$ |
0.19 |
|
|
|
$ |
(1.95 |
) |
|
|
$ |
1.09 |
|
|
|
$ |
(2.29 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||||||
Basic |
|
33,620 |
|
|
|
33,439 |
|
|
|
33,541 |
|
|
|
33,396 |
|
|
||||
Diluted |
|
33,649 |
|
|
|
33,439 |
|
|
|
33,678 |
|
|
|
33,396 |
|
|
|
|||||||||||||||||||
|
|||||||||||||||||||
(In Thousands) |
|||||||||||||||||||
(Unaudited) |
|||||||||||||||||||
|
|
|
|
||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
||||||||||||||||
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||||||
|
|
|
|
|
|
|
|
||||||||||||
Aluminum Extrusions |
$ |
137,086 |
|
|
|
$ |
115,621 |
|
|
|
$ |
394,492 |
|
|
|
$ |
339,566 |
|
|
|
28,501 |
|
|
|
26,440 |
|
|
|
87,885 |
|
|
|
103,444 |
|
|
||||
|
36,666 |
|
|
|
35,856 |
|
|
|
102,560 |
|
|
|
100,534 |
|
|
||||
Total net sales |
202,253 |
|
|
|
177,917 |
|
|
|
584,937 |
|
|
|
543,544 |
|
|
||||
Add back freight |
7,264 |
|
|
|
6,453 |
|
|
|
20,531 |
|
|
|
19,222 |
|
|
||||
Sales as shown in the Condensed Consolidated Statements of Income |
$ |
209,517 |
|
|
|
$ |
184,370 |
|
|
|
$ |
605,468 |
|
|
|
$ |
562,766 |
|
|
EBITDA from Ongoing Operations |
|
|
|
|
|
|
|
||||||||||||
Aluminum Extrusions: |
|
|
|
|
|
|
|
||||||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||||||
EBITDA (b) |
$ |
12,038 |
|
|
|
$ |
16,540 |
|
|
|
$ |
45,062 |
|
|
|
$ |
41,496 |
|
|
Depreciation & amortization |
(3,900 |
) |
|
|
(4,251 |
) |
|
|
(12,062 |
) |
|
|
(12,632 |
) |
|
||||
EBIT (b) |
8,138 |
|
|
|
12,289 |
|
|
|
33,000 |
|
|
|
28,864 |
|
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(160 |
) |
|
|
(720 |
) |
|
|
(223 |
) |
|
|
(2,637 |
) |
|
||||
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(13,696 |
) |
|
||||
|
|
|
|
|
|
|
|
||||||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||||||
EBITDA (b) |
4,821 |
|
|
|
6,041 |
|
|
|
21,035 |
|
|
|
33,928 |
|
|
||||
Depreciation & amortization |
(1,591 |
) |
|
|
(1,785 |
) |
|
|
(4,681 |
) |
|
|
(4,868 |
) |
|
||||
EBIT (b) |
3,230 |
|
|
|
4,256 |
|
|
|
16,354 |
|
|
|
29,060 |
|
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(182 |
) |
|
|
(56 |
) |
|
|
(457 |
) |
|
|
(225 |
) |
|
||||
|
|
|
|
|
|
|
|
||||||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||||||
EBITDA (b) |
7,396 |
|
|
|
9,546 |
|
|
|
25,296 |
|
|
|
22,594 |
|
|
||||
Depreciation & amortization |
(493 |
) |
|
|
(443 |
) |
|
|
(1,466 |
) |
|
|
(1,306 |
) |
|
||||
EBIT (b) |
6,903 |
|
|
|
9,103 |
|
|
|
23,830 |
|
|
|
21,288 |
|
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(7 |
) |
|
|
(3 |
) |
|
|
8,407 |
|
|
|
(14 |
) |
|
||||
Total |
17,922 |
|
|
|
24,869 |
|
|
|
80,911 |
|
|
|
62,640 |
|
|
||||
Interest income |
8 |
|
|
|
11 |
|
|
|
40 |
|
|
|
43 |
|
|
||||
Interest expense |
842 |
|
|
|
494 |
|
|
|
2,555 |
|
|
|
1,598 |
|
|
||||
Gain (loss) on investment in kaléo accounted for under fair value method (d) |
279 |
|
|
|
(36,200 |
) |
|
|
1,197 |
|
|
|
(61,000 |
) |
|
||||
Stock option-based compensation costs |
675 |
|
|
|
518 |
|
|
|
1,819 |
|
|
|
1,786 |
|
|
||||
Corporate expenses, net (c) |
8,555 |
|
|
|
10,586 |
|
|
|
30,470 |
|
|
|
29,915 |
|
|
||||
Income (loss) from continuing operations before income taxes |
8,137 |
|
|
|
(22,918 |
) |
|
|
47,304 |
|
|
|
(31,616 |
) |
|
||||
Income tax expense (benefit) |
1,908 |
|
|
|
(5,942 |
) |
|
|
10,728 |
|
|
|
(8,308 |
) |
|
||||
Net income (loss) from continuing operations |
6,229 |
|
|
|
(16,976 |
) |
|
|
36,576 |
|
|
|
(23,308 |
) |
|
||||
Net income (loss) from discontinued operations, net of tax |
(26 |
) |
|
|
(48,237 |
) |
|
|
(104 |
) |
|
|
(53,031 |
) |
|
||||
Net income (loss) |
$ |
6,203 |
|
|
|
$ |
(65,213 |
) |
|
|
$ |
36,472 |
|
|
|
$ |
(76,339 |
) |
|
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|
||||
|
|
|
|
|
||||
Assets |
|
|
|
|
||||
Cash & cash equivalents |
|
$ |
30,253 |
|
|
$ |
11,846 |
|
Accounts & other receivables, net |
|
97,185 |
|
|
86,327 |
|
||
Income taxes recoverable |
|
2,013 |
|
|
2,807 |
|
||
Inventories |
|
85,686 |
|
|
66,437 |
|
||
Prepaid expenses & other |
|
13,502 |
|
|
19,679 |
|
||
Current assets of discontinued operations |
|
151 |
|
|
1,339 |
|
||
Total current assets |
|
228,790 |
|
|
188,435 |
|
||
Property, plant & equipment, net |
|
167,953 |
|
|
166,545 |
|
||
Right-of-use leased assets |
|
14,453 |
|
|
16,037 |
|
||
Investment in kaléo (cost basis of |
|
35,479 |
|
|
34,600 |
|
||
Identifiable intangible assets, net |
|
16,608 |
|
|
18,820 |
|
||
|
|
67,708 |
|
|
67,708 |
|
||
Deferred income taxes |
|
12,101 |
|
|
19,068 |
|
||
Other assets |
|
2,591 |
|
|
3,506 |
|
||
Non-current assets of discontinued operations |
|
151 |
|
|
151 |
|
||
Total assets |
|
$ |
545,834 |
|
|
$ |
514,870 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||||
Accounts payable |
|
$ |
115,879 |
|
|
$ |
89,702 |
|
Accrued expenses |
|
31,672 |
|
|
40,741 |
|
||
Lease liability, short-term |
|
2,086 |
|
|
2,082 |
|
||
Income taxes payable |
|
56 |
|
|
706 |
|
||
Current liabilities of discontinued operations |
|
370 |
|
|
7,521 |
|
||
Total current liabilities |
|
150,063 |
|
|
140,752 |
|
||
Lease liability, long-term |
|
13,376 |
|
|
14,949 |
|
||
Long-term debt |
|
127,000 |
|
|
134,000 |
|
||
Pension and other postretirement benefit obligations, net |
|
102,970 |
|
|
110,585 |
|
||
Other non-current liabilities |
|
6,146 |
|
|
5,529 |
|
||
Shareholders’ equity |
|
146,279 |
|
|
109,055 |
|
||
Total liabilities and shareholders’ equity |
|
$ |
545,834 |
|
|
$ |
514,870 |
|
|
||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||
(In Thousands) |
||||||||||
(Unaudited) |
||||||||||
|
|
|
||||||||
|
|
Nine Months Ended |
||||||||
|
|
2021 |
|
|
2020 |
|
||||
Cash flows from operating activities: |
|
|
|
|
||||||
Net income (loss) |
|
$ |
36,472 |
|
|
|
$ |
(76,339 |
) |
|
Adjustments for noncash items: |
|
|
|
|
||||||
Depreciation |
|
16,169 |
|
|
|
23,218 |
|
|
||
Amortization of intangibles |
|
2,170 |
|
|
|
2,264 |
|
|
||
Reduction of right-of-use lease asset |
|
1,582 |
|
|
|
2,102 |
|
|
||
|
|
— |
|
|
|
13,696 |
|
|
||
Deferred income taxes |
|
4,120 |
|
|
|
(19,492 |
) |
|
||
Accrued pension income and post-retirement benefits |
|
10,622 |
|
|
|
10,701 |
|
|
||
Stock-based compensation expense |
|
3,227 |
|
|
|
4,120 |
|
|
||
(Gain) loss on investment accounted for under the fair value method |
|
(879 |
) |
|
|
61,000 |
|
|
||
Held for sale impairment loss on divested assets |
|
— |
|
|
|
45,054 |
|
|
||
Changes in assets and liabilities: |
|
|
|
|
||||||
Accounts and other receivables |
|
(11,379 |
) |
|
|
4,961 |
|
|
||
Inventories |
|
(19,902 |
) |
|
|
(2,761 |
) |
|
||
Income taxes recoverable/payable |
|
111 |
|
|
|
5,332 |
|
|
||
Prepaid expenses and other |
|
3,422 |
|
|
|
(5,305 |
) |
|
||
Accounts payable and accrued expenses |
|
12,078 |
|
|
|
(2,112 |
) |
|
||
Lease liability |
|
(1,566 |
) |
|
|
(2,245 |
) |
|
||
Pension and postretirement benefit plan contributions |
|
(5,510 |
) |
|
|
(2,254 |
) |
|
||
Other, net |
|
750 |
|
|
|
4,386 |
|
|
||
Net cash provided by operating activities |
|
51,487 |
|
|
|
66,326 |
|
|
||
Cash flows from investing activities: |
|
|
|
|
||||||
Capital expenditures |
|
(19,576 |
) |
|
|
(13,416 |
) |
|
||
Proceeds from the sale of assets |
|
4,749 |
|
|
|
— |
|
|
||
Net cash used in investing activities |
|
(14,827 |
) |
|
|
(13,416 |
) |
|
||
Cash flows from financing activities: |
|
|
|
|
||||||
Borrowings |
|
69,250 |
|
|
|
25,000 |
|
|
||
Debt principal payments |
|
(76,250 |
) |
|
|
(60,000 |
) |
|
||
Dividends paid |
|
(12,114 |
) |
|
|
(12,048 |
) |
|
||
Other |
|
915 |
|
|
|
(586 |
) |
|
||
Net cash used in financing activities |
|
(18,199 |
) |
|
|
(47,634 |
) |
|
||
Effect of exchange rate changes on cash |
|
(54 |
) |
|
|
(1,676 |
) |
|
||
Increase in cash and cash equivalents |
|
18,407 |
|
|
|
3,600 |
|
|
||
Cash and cash equivalents at beginning of period |
|
11,846 |
|
|
|
31,422 |
|
|
||
Cash and cash equivalents at end of period |
|
$ |
30,253 |
|
|
|
$ |
35,022 |
|
|
Notes to the Financial Tables
(Unaudited)
(a) Tredegar’s presentation of net income (loss) and diluted earnings (loss) per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings (loss) per share as reported under GAAP. Net income (loss) and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three and nine months ended
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
($ in millions, except per share data) |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||||||
Net income (loss) from continuing operations as reported under GAAP1 |
|
$ |
6.2 |
|
|
|
$ |
(17.0 |
) |
|
|
$ |
36.6 |
|
|
|
$ |
(23.3 |
) |
|
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
(0.1 |
) |
|
|
— |
|
|
|
0.2 |
|
|
|
0.1 |
|
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||||||
(Gain) loss associated with the investment in kaléo |
|
(0.2 |
) |
|
|
28.2 |
|
|
|
(1.0 |
) |
|
|
47.7 |
|
|
||||
One-time tax credit in |
|
— |
|
|
|
— |
|
|
|
(6.6 |
) |
|
|
— |
|
|
||||
Other |
|
1.3 |
|
|
|
2.0 |
|
|
|
4.2 |
|
|
|
6.1 |
|
|
||||
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10.5 |
|
|
||||
Net income (loss) from ongoing operations1 |
|
$ |
7.2 |
|
|
|
$ |
13.2 |
|
|
|
$ |
33.4 |
|
|
|
$ |
41.1 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Earnings (loss) per share from continuing operations as reported under GAAP (diluted) |
|
$ |
0.19 |
|
|
|
$ |
(0.51 |
) |
|
|
$ |
1.09 |
|
|
|
$ |
(0.70 |
) |
|
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
— |
|
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||||||
(Gain) loss associated with the investment in kaléo |
|
(0.01 |
) |
|
|
0.84 |
|
|
|
(0.03 |
) |
|
|
1.43 |
|
|
||||
One-time tax credit in |
|
— |
|
|
|
— |
|
|
|
(0.20 |
) |
|
|
— |
|
|
||||
Other |
|
0.04 |
|
|
|
0.06 |
|
|
|
0.13 |
|
|
|
0.17 |
|
|
||||
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.32 |
|
|
||||
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.22 |
|
|
|
$ |
0.39 |
|
|
|
$ |
1.00 |
|
|
|
$ |
1.22 |
|
|
1. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (f).
2. For more information, see Note 13 in the Notes to Financial Statements in the Form 10-Q for the quarter ended |
(b) EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 11 in the Notes to Financial Statements in the Form 10-Q for the quarter ended
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. The Company believes that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
(c) Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the three and nine months ended
|
Three Months Ended |
Nine Months Ended |
||||||||||||||
|
|
|||||||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||||
Environmental charges at |
$ |
0.1 |
|
|
$ |
0.1 |
|
|
$ |
0.1 |
|
|
$ |
— |
|
|
COVID-19-related expenses, net of relief 2 |
0.1 |
|
|
0.1 |
|
|
0.1 |
|
|
0.1 |
|
|
||||
Total for Aluminum Extrusions |
$ |
0.2 |
|
|
$ |
0.2 |
|
|
$ |
0.2 |
|
|
$ |
0.1 |
|
|
|
|
|
|
|
||||||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||||||
Other restructuring costs - severance |
$ |
0.1 |
|
|
$ |
0.1 |
|
|
0.1 |
|
|
0.1 |
|
|
||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||||
COVID-19-related expenses2 |
0.1 |
|
|
0.1 |
|
|
0.4 |
|
|
0.3 |
|
|
||||
Total for |
$ |
0.2 |
|
|
$ |
0.2 |
|
|
$ |
0.5 |
|
|
$ |
0.4 |
|
|
|
|
|
|
|
||||||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||||
One-time tax credit in |
$ |
— |
|
|
$ |
— |
|
|
$ |
(8.5 |
) |
|
$ |
(6.6 |
) |
|
COVID-19-related expenses2 |
— |
|
|
— |
|
|
0.1 |
|
|
0.1 |
|
|
||||
Total for |
$ |
— |
|
|
$ |
— |
|
|
$ |
(8.4 |
) |
|
$ |
(6.5 |
) |
|
Corporate: |
|
|
||||||||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||||||
(Gain), net of costs associated with the sale of the |
$ |
(0.2 |
) |
|
$ |
(0.2 |
) |
|
$ |
0.1 |
|
|
$ |
0.1 |
|
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; and business development activities1 |
1.5 |
|
1.1 |
|
4.4 |
|
3.5 |
|
||||||||
Write-down of investment in |
— |
|
|
— |
|
|
0.5 |
|
0.4 |
|
||||||
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend1 |
(0.1 |
) |
|
(0.1 |
) |
|
0.3 |
|
|
0.2 |
|
|
||||
Transition service fees, net of corporate costs associated with the divested |
0.1 |
|
|
0.1 |
|
|
(0.5 |
) |
|
(0.4 |
) |
|
||||
Total for Corporate |
$ |
1.3 |
|
|
$ |
0.9 |
|
|
$ |
4.8 |
|
|
$ |
3.8 |
|
|
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. 2. Included in “Other income (expense), net” in the condensed consolidated statements of income. 3. Included in “Costs of goods sold” in the condensed consolidated statements of income.
4. For more information, see Note 13 in the Notes to Financial Statements in the Form 10-Q for the quarter ended |
|
Three Months Ended |
Nine Months Ended |
||||||||||
|
|
|||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Consulting expenses for enterprise resource planning feasibility study2 |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
1.2 |
|
$ |
0.9 |
|
COVID-19-related expenses, net of relief 3 |
0.5 |
|
0.4 |
|
1.4 |
|
1.1 |
|
||||
Total for Aluminum Extrusions |
$ |
0.8 |
|
$ |
0.6 |
|
$ |
2.6 |
|
$ |
2.0 |
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Other restructuring costs - severance |
$ |
— |
|
$ |
— |
|
$ |
0.1 |
|
$ |
— |
|
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
COVID-19-related expenses3 |
— |
|
— |
|
0.2 |
|
0.1 |
|
||||
Total for |
$ |
— |
|
$ |
— |
|
$ |
0.3 |
|
$ |
0.1 |
|
Corporate: |
|
|
|
|
||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; and business development activities2 |
$ |
0.6 |
|
$ |
0.4 |
|
$ |
4.1 |
|
$ |
3.2 |
|
Corporate costs associated with the divested Personal Care business2 |
1.1 |
|
0.9 |
|
1.1 |
|
0.9 |
|
||||
Write-down of investment in |
0.1 |
|
0.1 |
|
0.3 |
|
0.2 |
|
||||
Accelerated recognition of stock-based compensation expense2 |
— |
|
— |
|
0.1 |
|
0.1 |
|
||||
|
— |
|
— |
|
— |
|
(0.6) |
|
||||
Total for Corporate |
$ |
1.8 |
|
$ |
1.4 |
|
$ |
5.6 |
|
$ |
3.8 |
|
1. Included in "Income tax expense (benefit)" in condensed consolidated statements of income. 2. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. 3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
(d) A gain on the Company’s investment in kaléo of
(e) In the first quarter of 2020, the operations of Aluminum Extrusions’
(f) Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations, and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) from continuing operations as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. It excludes items that we believe do not relate to Tredegar’s ongoing operations.
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and nine months ended
($ in millions) |
Pre-tax |
|
Tax Expense (Benefit) |
|
After-Tax |
|
Effective Tax Rate |
||||||||||
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
||||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
8.1 |
|
|
|
$ |
1.9 |
|
|
|
$ |
6.2 |
|
|
|
23.5 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
(0.1 |
) |
|
|
— |
|
|
|
(0.1 |
) |
|
|
|
||||
(Gains) losses from sale of assets and other |
1.5 |
|
|
|
0.4 |
|
|
|
1.1 |
|
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
9.5 |
|
|
|
$ |
2.3 |
|
|
|
$ |
7.2 |
|
|
|
24.2 |
% |
Three Months Ended |
|
|
|
|
|
|
|
||||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(22.9 |
) |
|
|
$ |
(5.9 |
) |
|
|
$ |
(17.0 |
) |
|
|
25.8 |
% |
(Gains) losses from sale of assets and other |
38.8 |
|
|
|
8.6 |
|
|
|
30.2 |
|
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
15.9 |
|
|
|
$ |
2.7 |
|
|
|
$ |
13.2 |
|
|
|
17.1 |
% |
Nine Months Ended |
|
|
|
|
|
|
|
||||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
47.3 |
|
|
|
$ |
10.7 |
|
|
|
$ |
36.6 |
|
|
|
22.7 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.2 |
|
|
|
— |
|
|
|
0.2 |
|
|
|
|
||||
(Gains) losses from sale of assets and other |
(4.3 |
) |
|
|
(0.9 |
) |
|
|
(3.4 |
) |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
43.2 |
|
|
|
$ |
9.8 |
|
|
|
$ |
33.4 |
|
|
|
22.7 |
% |
Nine Months Ended |
|
|
|
|
|
|
|
||||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(31.6 |
) |
|
|
$ |
(8.3 |
) |
|
|
$ |
(23.3 |
) |
|
|
26.2 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.1 |
|
|
|
— |
|
|
|
0.1 |
|
|
|
|
||||
(Gain) loss associated with the investment in kaléo |
61.0 |
|
|
|
13.3 |
|
|
|
47.7 |
|
|
|
|
||||
(Gains) losses from sale of assets and other |
8.4 |
|
|
|
2.3 |
|
|
|
6.1 |
|
|
|
|
||||
|
13.7 |
|
|
|
3.2 |
|
|
|
10.5 |
|
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
51.6 |
|
|
|
$ |
10.5 |
|
|
|
$ |
41.1 |
|
|
|
20.4 |
% |
(g) Net debt is calculated as follows:
|
|
|
|
|
||||
(in millions) |
|
2021 |
|
2020 |
||||
Debt |
|
$ |
127.0 |
|
|
$ |
134.0 |
|
Less: Cash and cash equivalents |
|
30.3 |
|
|
11.8 |
|
||
Net debt |
|
$ |
96.7 |
|
|
$ |
122.2 |
|
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes.
(h) Represents a one-time tax credit in
View source version on businesswire.com: https://www.businesswire.com/news/home/20211105005147/en/
neill.bellamy@tredegar.com
Source: